SGRY Surgery Partners, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Surgery Partners, Inc. (SGRY) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on March 2, 2026, a 10-Q quarterly report filed on November 10, 2025, an 8-K current report filed on March 2, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Surgery Partners, Inc. (SGRY) (SEC CIK 1638833), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Business Overview
- • Core business: Management and operation of surgical facilities primarily focused on outpatient surgical procedures
- • New emphasis: Increased revenue diversification from management and administrative services in non-owned surgical facilities
Risk Factors
- • Regulatory risk from One Big Beautiful Bill Act (OBBBA), effective July 4, 2025, increasing Medicaid and Medicare regulatory burdens
- • Macroeconomic exposure to government payors, comprising 42.8% of patient service revenues in 2025
Management Discussion & Analysis
- • Adjusted EBITDA $526.2M in 2025 vs $508.2M in 2024, income before taxes $116.9M vs $147.1M in 2024
- • Operating cash flow $274.3M in 2025, Credit Agreement EBITDA $578.2M reflecting acquisitions and synergies
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 7.01: Regulation FD Disclosure
- • Earnings call scheduled March 3, 2026 at 8:30 a.m. ET for Q4 and full-year 2025 results
- • Presentation available on IR website and filed as Exhibit 99.2 alongside press release
Item 2.02: Results of Operations and Financial Condition
- • Q4 and full-year 2025 earnings released March 2, 2026 — full results in Exhibit 99.1
- • Non-GAAP measures used with GAAP reconciliation included in the press release
Annual Reports Archive10-K
AI-powered analysis of Surgery Partners, Inc. (SGRY) 10-K annual reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Surgery Partners, Inc. (SGRY) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $2.5B | $2.7B | $3.1B | $3.3B |
| Operating Income | $345.2M | $328.0M | $348.8M | $389.5M |
| Net Income | -$54.6M | -$11.9M | -$168.1M | -$77.9M |
| Op. Margin | 13.6% | 12.0% | 11.2% | 11.8% |
| Net Margin | -2.2% | -0.4% | -5.4% | -2.4% |
| Balance Sheet | ||||
| Total Assets | $6.7B | $6.9B | $7.9B | $8.1B |
| Equity | $2.0B | $2.0B | $1.8B | $1.7B |
| ROE | -2.7% | -0.6% | -9.4% | -4.5% |
Source: XBRL financial data from Surgery Partners, Inc. (SGRY) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
10-K | Mar 2, 2026 | Dec 31, 2025 | Analysis | |
8-K | Mar 2, 2026 | — | Analysis | — |
8-K | Dec 16, 2025 | — | — | |
8-K | Dec 12, 2025 | — | — | |
8-K | Dec 11, 2025 | — | — | |
10-Q | Nov 10, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 5, 2025 | Jun 30, 2025 | — | |
10-Q | May 12, 2025 | Mar 31, 2025 | — | |
10-K | Mar 7, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 12, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 6, 2024 | Jun 30, 2024 | — | |
10-Q | May 7, 2024 | Mar 31, 2024 | — | |
10-K | Feb 26, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 7, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 1, 2023 | Jun 30, 2023 | — | |
10-Q | May 2, 2023 | Mar 31, 2023 | — | |
10-K | Mar 1, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 8, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 2, 2022 | Jun 30, 2022 | — | |
10-Q | May 3, 2022 | Mar 31, 2022 | — | |
10-K | Mar 1, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 3, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 4, 2021 | Jun 30, 2021 | — | |
10-Q | May 5, 2021 | Mar 31, 2021 | — | |
10-K | Mar 10, 2021 | Dec 31, 2020 | — |
Frequently Asked Questions
What are the latest SGRY SEC filings in 2026?
Surgery Partners, Inc. (SGRY) has filed a 10-K annual report on March 2, 2026, a 10-Q quarterly report on November 10, 2025, an 8-K current report on March 2, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did SGRY file its most recent 10-K annual report?
Surgery Partners, Inc. (SGRY) filed its most recent 10-K annual report on March 2, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view SGRY 10-Q quarterly reports?
Surgery Partners, Inc. (SGRY)'s most recent 10-Q quarterly report was filed on November 10, 2025. SignalX displays every SGRY 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has SGRY filed recently?
Surgery Partners, Inc. (SGRY)'s most recent 8-K was filed on March 2, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find SGRY insider trading activity (Form 4)?
SignalX aggregates every SGRY Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does SGRY file with the SEC?
Surgery Partners, Inc. (SGRY) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new SGRY filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Surgery Partners, Inc. (SGRY).
What is SGRY's SEC CIK number?
Surgery Partners, Inc. (SGRY)'s SEC CIK (Central Index Key) number is 1638833. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1638833 to look up all SGRY filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find SGRY return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Surgery Partners, Inc. (SGRY) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Surgery Partners, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 46+ filings.